Home » Needham gives Biogen a buy rating, predicts big rally despite controversy around Alzheimer's drug

Needham gives Biogen a buy rating, predicts big rally despite controversy around Alzheimer's drug

  • 8 months ago
  • Read Time: 0 minute
  • by admin



The rollout of Aduhelm is facing "near-term challenges," according to Biogen.



Source link

Prev post Glassdoor CEO: Acquisition of Fishbowl will be good for job seekers and employers
Next post Christina Aguilera makes heads turn in her all-white look

admin

Related Posts

Back to top